Encompass Health Corp (EHC) stock
Close on Nov 10, 2026Market cap $14.06BP/E 23.2Yield 0.51%
Encompass Health Corp grew revenue 9.5% to $6.21B over the twelve months to Jun 30, 2026. Free cash flow was $413.40M, down 5.9% from a year earlier. At the latest close the market valued the company at $14.06B, 23.2 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $14.06B
- P/E ratio
- 23.2
- Price to sales
- 2.27
- Price to book
- 5.41
- Dividend yield
- 0.51%
- Free cash flow yield
- 2.94%
Fundamentals
- Revenue
- $6.21B
- Net income
- $621.00M
- EPS, diluted
- $6.14
- Free cash flow
- $413.40M
- Book value per share
- $25.98
- Diluted shares
- 100M
Trading
- Next earnings
- Feb 4, 2027 (estimated, during market hours)
- Previous close
- $141.15
- Open
- $141.30
- Day's range
- $140.28 – $142.85
- Volume
- 1,001,771
- Average volume (20 days)
- 1,281,076
- Index membership
- S&P MidCap 400, Russell 1000, Russell 3000
- Beta (5 years)
- 0.68
- 52-week range
- $92.77 – $143.36
- RSI (14 days)
- 68.7
- Volatility (1 year)
- 30.5%
- Relative volume
- 1.00×
- WACC
- 7.6%
Index membership is inferred from the holdings of funds that track each index (IJH, SPMD, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2009, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 10, 2026. The S&P 500 is measured by the SPY fund.
| Period | EHC | S&P 500 | Difference | EHC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +15.6% | -3.7% | +19.2 pts | ||
| 3 months | +13.5% | -2.7% | +16.2 pts | ||
| Year to date | +35.3% | +10.8% | +24.4 pts | ||
| 1 year | +24.6% | +11.2% | +13.4 pts | ||
| 3 years | +131.7% | +76.5% | +55.2 pts | +32.3% | +20.8% |
| 5 years | +189.5% | +72.9% | +116.6 pts | +23.7% | +11.6% |
| 10 years | +426.4% | +304.8% | +121.5 pts | +18.1% | +15.0% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Encompass Health filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Results
- Results
- Results
- News
About Encompass Health
Services-Hospitals
Encompass Health operates as a provider of inpatient rehabilitation services, owning and managing specialized hospitals dedicated to post-acute recovery. The organization delivers intensive rehabilitative therapy and medical care to individuals recovering from major illnesses and injuries—including strokes, hip fractures, and debilitating neurological conditions—aiming to restore cognitive and physical functioning. Care is delivered through an interdisciplinary model involving specialized nurses, therapists, and case managers utilizing advanced clinical protocols and technology. Nearly all patients enter these facilities via physician referrals following acute-care hospital stays, with Medicare, Medicare Advantage, and managed care plans serving as the primary sources of payment for these nondiscretionary healthcare services.
Company profile, executives and historyEncompass Health stock: common questions
What is Encompass Health's stock price?
EHC closed at $142.51 on Nov 10, 2026, up 0.96% on the day. Over the past 52 weeks it traded between $92.77 and $143.36.
What is Encompass Health's market cap?
Encompass Health was worth $14.06B at the close on Nov 10, 2026: the share price times the diluted shares outstanding.
What is EHC's P/E ratio?
EHC trades at 23.2 times earnings, based on diluted earnings per share of $6.14 over the twelve months to Jun 30, 2026.
How much revenue does Encompass Health make?
Encompass Health reported revenue of $6.21B for the twelve months to Jun 30, 2026, up 9.5% from a year earlier.
Does Encompass Health pay a dividend?
Yes. Encompass Health paid $0.72 per share over the last twelve months, a yield of 0.51% at the latest price, and has raised its annual dividend 2 years in a row.
When does Encompass Health report earnings next?
Encompass Health is expected to report Q4 FY2026 results on Feb 4, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has EHC stock performed over the past year?
Including dividends, EHC returned +24.6% over the past year, against +11.2% for the S&P 500.
How many EHC shares are sold short?
4M shares were sold short at the latest FINRA report, 3.70% of the float, or 2.7 days of average trading volume.
Who are Encompass Health's competitors?
Companies most similar to Encompass Health by business, industry and size include CYH, ARDT, PACS, ENSG, UHS.
See a number that looks wrong?